Tag Archives: seminars

Invited Guest: Dr. Nancy Smider, Director of Research Informatics at Epic

We have invited Dr. Nancy Smider, Director of Research Informatics, at Epic Corporation in Madison, Wisconsin to visit and speak to our faculty about the EHR’s research roadmap and future EHR functionality. The meeting will be held on February 1, 2018 @ Noon in Hope 216. Lunch will be provided. All are welcome to attend.

Epic Enabling Research

Guest speaker:

Nancy Smider, PhD

Director, Research Informatics

Epic Corporation in Madison, Wisconsin

Hope 216

February 1, 2018

12 Noon

Nancy Smider, PhD

Director, Research Informatics


Nancy Smider, PhD, is the Director of Research Informatics at Epic. She focuses on Epic’s electronic health record system as an enabling and accelerating technology in support of the clinical research mission of organizations. Nancy also leads Epic’s annual Research Advisory Council conference which draws over 400 attendees from more than 150 of Epic’s customers, providing a broad perspective on the research-related efforts of leading healthcare organizations across the country, and globally. Nancy earned her PhD in 1993 from the University of Wisconsin, Madison. She did her Post-Doctoral fellowship in health services research, after which she accepted a position as a Research Scientist at the University of Wisconsin, School of Medicine, where she continued her work as part of a multi-disciplinary team examining biopsychosocial models of health and disease. She joined Epic in 2001

REGISTER NOW: Yale Policy, Politics & Law of Cancer Conference, Feb. 8-9, 2018


Yale Law School and Yale Cancer Center are hosting an all-star conference on the Policy, Politics and Law of Cancer on Thursday, February 8th and Friday, February 9th at Yale Law School.

Speakers include Harold Varmus, Siddhartha Mukherjee, Ned Sharpless, Levi Garraway and many others. We thought this gathering would be of special interest to members of the Combined Program in the Biological and Biomedical Sciences and we would be delighted if you wished to join us.

The agenda and registration button is below.

Please save the date for a Conference Co-Sponsored by Yale Cancer Center and Smilow Cancer Hospital on

February 8-9, 2018 at Yale Law School

A major interdisciplinary conference addressing topics at the cutting edge of cancer policy, including the role that Washington, D.C. plays in cancer research and treatment; the business of cancer; disparities in cancer; legal and ethical issues associated with cutting edge therapies; and the cost of cancer treatment
Register Now

Keynote Speakers

Siddhartha Mukherjee, MD, DPhil: Author of The Emperor of All Maladies and Assistant Professor of Medicine, Columbia University Medical Center

Norman Sharpless
, MD: Director, National Cancer Institute

Conference Speakers

More in Progress

  • Peter Bach, MD, MAPP: Director of the Center for Health Policy and Outcomes, Memorial Sloan Kettering Cancer Center
  • Robert Bazell, PhD: Professor (Adjunct) of Molecular, Cellular, and Developmental Biology, Yale University
  • Edward Benz, MD: President and CEO Emeritus, Dana-Farber Cancer Institute
  • Gideon Blumenthal, MD: Deputy Director (Acting), Office of Hematology Oncology Products, U.S. Food and Drug Administration
  • Otis Brawley, MD: Chief Medical Officer, American Cancer Society
  • Erik Fatemi: Senior Vice President, Cornerstone Government Affairs
  • Howard Forman, MD, MBA: Professor of Radiology and Biomedical Imaging, Public Health (Health Policy) and Professor of Epidemiology (Chronic Diseases), Yale School of Medicine
  • Charles Fuchs, MD, MPH: Director of Yale Cancer Center and Physician-in-Chief of Smilow Cancer Hospital
  • Levi Garraway, MD, PhD: Senior Vice President, Global Development & Medical Affairs, Eli Lilly; Director, Joint Center for Cancer Precision Medicine
  • Abbe Gluck, JD: Professor of Law and Faculty Director, Solomon Center for Health Law and Policy, Yale Law School
  • Nancy Goodman, JD, MPP: Executive Director, Kids Against Cancer
  • Cary Gross, MD: Professor of Medicine (General Medicine) and Epidemiology (Chronic Diseases), Yale School of Medicine
  • Peggy Hamburg, MD: Former Commissioner of the FDA (2009-2015)
  • Roy Herbst, MD, PhD: Ensign Professor of Medicine (Medical Oncology) and Professor of Pharmacology, Yale School of Medicine; Chief of Medical Oncology, Yale Cancer Center and Smilow Cancer Hospital
  • Amy Kapczynski, JD: Professor of Law and Faculty Director, Global Health Justice Partnership, Yale Law School
  • Aaron Kesselheim, MD, JD, MPH: Associate Professor of Medicine, Harvard Medical School; Director of the Program on Regulation, Therapeutics and Law at Brigham and Women’s Hospital
  • Jorge Lopez, Jr., JD: Executive Vice President and General Counsel, Memorial Sloan Kettering Cancer Center
  • Abe Lopman, MBA: Senior Vice President, Operations; Executive Director, Smilow Cancer Hospital at Yale New Haven
  • Dayna Bowen Matthew, JD: William L. Matheson and Robert M. Morgenthau Distinguished Professor of Law, University of Virginia School of Law
  • Barbara McAneny, MD: Co-Founder and CEO, New Mexico Oncology Hematology Consultants
  • Lee Newcomer, MD, MHA: Senior Vice President, Oncology, Genetics and Women’s Health, UnitedHealthcare
  • Randall Oyer, MD: Medical Director, Oncology Program, Lancaster General Hospital
  • Blase Polite, MD: Associate Professor of Medicine, University of Chicago Medical Center
  • Katerina Politi, PhD: Associate Professor, Yale School of Medicine
  • Nicholson Price, JD, PhD: Assistant Professor of Law, University of Michigan Law School
  • Gregory Raskin, MD: Vice President, Technology Development, Memorial Sloan Kettering Cancer Center
  • Jessica Roberts, JD: Associate Professor and Director, Health Law & Policy Institute, University of Houston Law Center
  • Joseph Ross, MD, MHS: Associate Professor of Medicine (General Medicine) and Associate Professor of Public Health (Health Policy), Yale School of Medicine
  • Eugene Rusyn, JD: Lecturer in Law and Senior Fellow, Solomon Center for Health Law and Policy, Yale Law School
  • Charles Sawyers, MD: Chair, Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center
  • Richard Schilsky, MD: Chief Medical Officer, American Society of Clinical Oncology
  • Deborah Schrag, MD, MPH: Chief, Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute; Professor of Medicine, Harvard Medical School
  • Jeffrey Schwartz, MBA: Managing Director, Bain Capital Life Sciences
  • Ellen Sigal, PhD: Chairperson and Founder, Friends of Cancer Research
  • Harold Varmus, MD: Lewis Thomas University Professor of Medicine, Weill Cornell Medical College; Former Director of National Cancer Institute & the National Institutes of Health; and former President & CEO of Memorial Sloan Kettering Cancer Center
  • Lindsay Wiley, JD, MPH: Professor of Law and Director, Health Law and Policy Program, American University Washington College of Law

Additional participants from the Yale community expected.


For the agenda and conference updates, please check the conference website.

Thursday, February 8, 2018
4:00 p.m. – 6:45 p.m.

Friday, February 9, 2018
8:30 a.m. – 5:00 p.m.

Sterling Law Building, Yale Law School
127 Wall Street, New Haven

Free & Open to the Public
All are Welcome

Shuttles to and from the Sterling Law Building and the Yale School of Medicine will be provided throughout the day timed for arrival and departure for each panel presentation.

This event is supported by the Oscar M. Ruebhausen Fund at Yale Law School.

Email the Solomon Center for more information

Math-applied APPLIED MATH PROGRAM: Seminar & Refreshments ~ Thursday, December 7, 2017

*Non-standard Day, location and time*


Speaker: Guy Gilboa, Faculty of electrical engineering, Technion

Date: Thursday, December 7, 2017

Time: 4:00 p.m. Refreshments (AKW, 1st Floor Break Area)
4:15p.m. Seminar (AKW 400)

Title: Processing images using nonlinear transforms

Abstract: Recent studies of convex functionals and their related nonlinear eigenvalue problems show surprising analogies to harmonic analysis based on classical transforms (e.g. Fourier). In this talk the total-variation transform will be introduced along with some theoretical results. Applications related to image decomposition, texture processing and face fusion will be shown. Extensions to graphs and a new interpretation of gradient descent will also be discussed.
Guy Gilboa Flyer.pdf

YSBupdates New YSB Project Update

Please join the project team for the quarterly Yale Science Building Town Hall on Monday, December 11th at 4pm in Sloane Physics Lab 59. This project update meeting will include a review of upcoming work inside the Kline Biology Tower lobby over the winter break, and work adjacent to Kline Biology Tower moving in to the new year.

A new Town Hall Meeting has been posted to the Yale Science Building project website. Please visit http://yalesciencebuilding.yale.edu/ to view.

SBI Retreat- Please Registration

Not sure this is open to all. Best to check.


Please join us for Yale SBI Fall Retreat on Tuesday, November 21st held at the Yale Maurice R. Greenberg Conference Center. We want to use this event to primarily enhance the awareness of research directions in different labs, particularly empaneling the new directions and recent exciting developments. Attached is a draft schedule for the day.

Please register here https://westcampus.yale.edu/sbi-fall-retreat-registration

Meredith Morrow

Senior Administrative Assistant

Yale University, West Campus Administration

Systems Biology Institute

Andre Levchenko, Sidi Chen, and Michael Murrell

Telephone: (203) 737-6712


Schedule Version 1_ Yale Systems Biology Institute Fall Retreat.pdf

Links to “Oncology at the Limits” and TRACERx Consortium

Here is a link to the “Oncology at the Limits” Conference which is co-organised between UCL and Yale, …. It will be from
19th to 21st March at the Royal College of Physicians in London.



The Keynote this year was … about the Lung TRACERx consortium. It is a project which
performs multi-site sampling of tumours to gain an insight into subclonal populations, and also follows up on the presence, expansion or response to therapy of these subclones via circulating-tumour-DNA. …